Merck & Co., Inc. (MRK)
147.61
-1.93
(-1.29%)
USD |
NYSE |
Aug 28, 14:23
Merck Debt to Equity Ratio : 1.286 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.286 |
| March 31, 2026 | 1.071 |
| December 31, 2025 | 0.9606 |
| September 30, 2025 | 0.798 |
| June 30, 2025 | 0.7226 |
| March 31, 2025 | 0.7209 |
| December 31, 2024 | 0.8263 |
| September 30, 2024 | 0.8568 |
| June 30, 2024 | 0.8671 |
| March 31, 2024 | 0.8478 |
| December 31, 2023 | 0.9651 |
| September 30, 2023 | 0.8451 |
| June 30, 2023 | 0.9539 |
| March 31, 2023 | 0.6565 |
| December 31, 2022 | 0.6955 |
| September 30, 2022 | 0.6842 |
| June 30, 2022 | 0.7322 |
| March 31, 2022 | 0.7777 |
| December 31, 2021 | 0.907 |
| September 30, 2021 | 0.7387 |
| June 30, 2021 | 0.7966 |
| March 31, 2021 | 1.160 |
| December 31, 2020 | 1.320 |
| September 30, 2020 | 0.9848 |
| June 30, 2020 | 1.117 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.068 |
| December 31, 2019 | 1.056 |
| September 30, 2019 | 1.010 |
| June 30, 2019 | 0.998 |
| March 31, 2019 | 0.9776 |
| December 31, 2018 | 0.9406 |
| September 30, 2018 | 0.7277 |
| June 30, 2018 | 0.7175 |
| March 31, 2018 | 0.6997 |
| December 31, 2017 | 0.7109 |
| September 30, 2017 | 0.7058 |
| June 30, 2017 | 0.6306 |
| March 31, 2017 | 0.7148 |
| December 31, 2016 | 0.6197 |
| September 30, 2016 | 0.5748 |
| June 30, 2016 | 0.5601 |
| March 31, 2016 | 0.5883 |
| December 31, 2015 | 0.5935 |
| September 30, 2015 | 0.585 |
| June 30, 2015 | 0.5717 |
| March 31, 2015 | 0.633 |
| December 31, 2014 | 0.44 |
| September 30, 2014 | 0.6156 |
| June 30, 2014 | 0.477 |
| March 31, 2014 | 0.5632 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
| Pfizer Inc. | 0.7418 |
| Bristol Myers Squibb Co. | 2.019 |
| Abbott Laboratories | 0.638 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 129.80B |
| Total Liabilities (Quarterly) | 87.82B |
| Shareholders Equity (Quarterly) | 41.93B |
| Current Ratio | 1.323 |
| Net Debt Paydown Yield | -1.20% |